Glucose sparing in peritoneal dialysis: Implications and metrics

Slides:

Advertisements

Similar presentations

Peritoneal transport assessment by peritoneal equilibration test with 3.86% glucose: A long-term prospective evaluation V. La Milia, P. Pozzoni, G. Virga,

Advertisements

Acid-base profile in patients on PD

Home care assistance and the utilization of peritoneal dialysis

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

F.H. Bender, J. Bernardini, B. Piraino Kidney International

Linear and logistic regression analysis

Buffer transport in peritoneal dialysis

Volume 70, Pages S138-S145 (November 2006)

Acid-base profile in patients on PD

Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis James F. Medcalf, Kevin P.G.

Volume 70, Pages S38-S43 (November 2006)

Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.

Use of icodextrin in high transport ultrafiltration failure

Confounding: What it is and how to deal with it

Impact of new dialysis solutions on peritonitis rates

Volume 72, Issue 8, Pages (October 2007)

Volume 64, Pages S3-S12 (December 2003)

Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy G. Viglino, L. Neri, S. Barbieri Kidney.

Volume 53, Issue 4, Pages (April 1998)

Volume 69, Issue 5, Pages (March 2006)

Fibrin plug Kidney International Volume 78, Issue 9, (November 2010)

Ali K. Abu-Alfa, John Burkart, Beth Piraino, Joe Pulliam, Salim Mujais

Volume 57, Issue 6, Pages (June 2000)

Volume 73, Issue 4, Pages (February 2008)

Volume 70, Pages S21-S25 (December 2006)

High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury D.P. Gabriel, J.T. Caramori,

Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: A simple assessment of symptom burden S.N. Davison, G.S.

French peritoneal dialysis registry (RDPLF): Outline and main results

S.G. John, N.M. Selby, C.W. McIntyre Kidney International

Anemia as a risk factor for chronic kidney disease

F.H. Bender, J. Bernardini, B. Piraino Kidney International

V. La Milia, M. Limardo, G. Virga, M. Crepaldi, F. Locatelli

A new era in phosphate binder therapy: What are the options?

Volume 70, Issue 11, Pages (December 2006)

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

The epidemiology of chronic kidney disease

Volume 73, Pages S5-S17 (April 2008)

Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments R. Mishler, J.J. Sands, N.J. Ofsthun,

Volume 73, Pages S94-S101 (April 2008)

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure A. Parikova, W. Smit, D.G. Struijk,

Blood pressure targets in hemodialysis patients

The third World Kidney Day: Looking back and thinking forward

Clifford J. Holmes, Dirk Faict Kidney International

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Microbiology and outcomes of peritonitis in North America

Alternate-day dialysis may be needed for hemodialysis patients

Nephrology Crossword: Peritoneal Dialysis

Randomized controlled study of biocompatible peritoneal dialysis solutions: Effect on residual renal function S.L.S. Fan, T. Pile, S. Punzalan, M.J.

Future of icodextrin as an osmotic agent in peritoneal dialysis

Profiling of peritoneal ultrafiltration

Volume 73, Pages S72-S75 (April 2008)

Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis N.-Y. Zalunardo, C.-L. Rose, I.W.Y.

Patient re-training in peritoneal dialysis: Why and when it is needed

Peter G. Blake, Arsh K. Jain, Sechelle Yohanna Kidney International

Organ transplantation goes to the movies

Volume 70, Pages S84-S90 (November 2006)

Volume 72, Issue 2, Pages (July 2007)

Adequacy of automated peritoneal dialysis with and without manual daytime exchange: A randomized controlled trial D. Demetriou, A. Habicht, M. Schillinger,

Charles A. Herzog Kidney International

Quantification of free water transport in peritoneal dialysis

Volume 70, Issue 3, Pages (August 2006)

Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate S. Aime, C. Canavese, P. Stratta Kidney International

Review of clinical trial experience with icodextrin

Volume 70, Issue 5, Pages (September 2006)

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins

Metabolic and laboratory effects of icodextrin

Presentation transcript:

Glucose sparing in peritoneal dialysis: Implications and metrics C. Holmes, S. Mujais Kidney International Volume 70, Pages S104-S109 (November 2006) DOI: 10.1038/sj.ki.5001924 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 Mathematical modeling of glucose absorption in CAPD patients with various membrane transport characteristics. The model assumes three shorts dwells of 5h and a long dwell of 9h. Legend: L=low (MTAC 5.96ml/min); LA=low-average (MTAC 8.35ml/min); HA=high-average (MTAC 11.7ml/min); H=high (MTAC 16.3ml/min). Kidney International 2006 70, S104-S109DOI: (10.1038/sj.ki.5001924) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Net UF during a PET with 2.5% dextrose displayed by PET categories. L=low transport; LA=low-average transport; HA=high-average transport; H=high transport. Kidney International 2006 70, S104-S109DOI: (10.1038/sj.ki.5001924) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 3 Glucose absorption during a PET with 2.5% dextrose displayed by PET categories. L=low transport; LA=low-average transport; HA=high-average transport; H=high transport. Kidney International 2006 70, S104-S109DOI: (10.1038/sj.ki.5001924) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 4 UF efficiency during a PET with 2.5% dextrose displayed by PET categories. L=low transport; LA=low-average transport; HA=high-average transport; H=high transport. Kidney International 2006 70, S104-S109DOI: (10.1038/sj.ki.5001924) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 5 Correlation between glucose absorption and net UF during a PET with 2.5% dextrose. Kidney International 2006 70, S104-S109DOI: (10.1038/sj.ki.5001924) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 6 Correlation between carbohydrate absorption from an icodextrin solution and net UF during a CAPD long dwell. Kidney International 2006 70, S104-S109DOI: (10.1038/sj.ki.5001924) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 7 Correlation between carbohydrate absorption from an icodextrin solution and net UF during an APD long dwell. Kidney International 2006 70, S104-S109DOI: (10.1038/sj.ki.5001924) Copyright © 2006 International Society of Nephrology Terms and Conditions